Scholars Central

Research articlePublished 2015

Regulation of the Human Delta-Opioid Receptor by Alkaloids: Different Roles of Arrestins

Authors: Elise Camacho, Benjamin Aguila, Nicolas Elie, Jana Sopkova, Caroline Marte, Audrey Davis, Cédric Lecoutey, Stéphane Allouche

Journal of Neuroscience and Neuropharmacology

Volume 1 · Issue 1 · Pages 1–8

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Study background: We previously revealed that the arrestin 2 was differentially involved in the regulation of the human delta opioid receptor (hDOR) by peptidic and alkaloid agonists. In the present study, we examined whether i) hDOR regulation by two related alkaloid agonists (etorphine and morphine) involved the same arrestins ii) similar arrestin-dependent mechanisms occur upon short- and long-term agonist exposure. Methods: The human neuroblastoma SK-N-BE cells, endogenously expressing hDOR, were transfected with wild-type or mutant arrestins. Using shRNA, we also generated a clonal cell line depleted in arrestin 2, the only arrestin isoform expressed in this cell line. Cells were then exposed or not to either morphine ou etorphine for short- (1 h) or long-term (18 h), then receptor desensitization was examined on the cAMP pathway and internalization was visualized by confocal microscopy. Results: In arrestin 2-depleted cells, we observed a strong reduction of desensitization after 18 h of morphine exposure but not with etorphine. Over-expression of wild-type or mutant arrestins produced an opposite modulation of receptor desensitization induced by morphine and etorphine both upon short- and long-term exposure. Confocal fluorescence microscopy experiments did not reveal any strong impact on receptor internalization when different arrestins were over-expressed. Conclusion: Our results showed that i) two related opioid alkaloid agonists produce hDOR desensitization by different mechanisms ii) the involvement of arrestins in hDOR desensitization depends on the duration of agonist exposure.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Neuroscience and Neuropharmacology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neuroscience and Neuropharmacology
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Elise Camacho”
  • BylineArticles whose byline prints “Benjamin Aguila”
  • BylineArticles whose byline prints “Nicolas Elie”
  • BylineArticles whose byline prints “Jana Sopkova”
  • BylineArticles whose byline prints “Caroline Marte”
  • BylineArticles whose byline prints “Audrey Davis”
  • BylineArticles whose byline prints “Cédric Lecoutey”
  • BylineArticles whose byline prints “Stéphane Allouche”